PIN1 and cancer: It is because Pin1 stimulates oncogenic pathways that Pin1 inhibitors show great promise in the development of new cancer therapies (Moore and Potter, 2013; Pinch et al., 2020; Wei et al., 2015; Campaner et al., 2017; Dubiella et al., 2021; Koikawa et al., 2021; Kozono et al., 2018).